End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
97.9 TWD | -1.21% | +3.38% | -14.12% |
Apr. 23 | Lin BioScience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Lin BioScience, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 8.95B 290B |
---|---|---|---|---|---|
Net income 2022 | -314M -10.18B | Net income 2023 | -687M -22.28B | EV / Sales 2022 | - |
Net cash position 2022 | 1.6B 51.85B | Net cash position 2023 | 3.22B 104B | EV / Sales 2023 | - |
P/E ratio 2022 |
-39.8
x | P/E ratio 2023 |
-12.3
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
1 day | -1.21% | ||
1 week | +3.38% | ||
Current month | +3.38% | ||
1 month | +6.99% | ||
3 months | -10.18% | ||
6 months | -19.75% | ||
Current year | -14.12% |
Managers | Title | Age | Since |
---|---|---|---|
Yue Hsin Lin
FOU | Founder | 46 | 16-05-11 |
Wan Shan Chen
DFI | Director of Finance/CFO | 38 | 16-05-31 |
Hung Wei Chen
COO | Chief Operating Officer | 43 | 16-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hsien Hua Huang
BRD | Director/Board Member | - | 18-09-26 |
San Chien Tu
BRD | Director/Board Member | - | 18-09-26 |
Chan Yue Li
BRD | Director/Board Member | 52 | 16-10-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +3.30% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 97.9 | -1.21% | 304,522 |
24-05-06 | 99.1 | +0.71% | 214,825 |
24-05-03 | 98.4 | 0.00% | 319,668 |
24-05-02 | 98.4 | +3.91% | 348,878 |
24-04-30 | 94.7 | -0.21% | 233,468 |
End-of-day quote Taipei Exchange, May 06, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-14.12% | 241M | |
+33.43% | 690B | |
+26.43% | 546B | |
-5.12% | 358B | |
+19.59% | 323B | |
+4.89% | 287B | |
+14.32% | 235B | |
+5.79% | 199B | |
-9.49% | 195B | |
+4.26% | 161B |
- Stock Market
- Equities
- 6696 Stock